Abstract: A radar-based environmental detection system for motor vehicles. The system includes at least one radar sensor for providing location data regarding objects in the environment of the motor vehicle, and including a neural network for converting the location data into an environmental model which represents spatio-temporal object data of the objects. The neural network is conditioned to give priority to outputting environmental models in which at least one predetermined physical relationship between the location data and the object data is satisfied.

Abstract: A method for demand-controlled supply to and disposal away from production stations. Self-propelled transport vehicles are moved on a rail within an overhead storage and transport system. A transport unit is requested by a transfer unit which forms a linking member between the storage and transport system and an associated production station. A transport task is assigned by a material flow control to a transport vehicle. The transport vehicle is moved in the transport plane on the rail from a start position to the transfer unit of a production station initiating the transport task. The transport unit is transferred to the transfer unit. The full or empty transport unit is lowered by a lift into a transfer plane located below a transport plane. The transport vehicle is released for the next transport task after the transfer of the full or empty transport unit to the transfer unit.

Abstract: The compounds of formula (I) in which R1, R11 and A have the meanings as given in the description are novel effective iNOS inhibitors.

Abstract: The compounds of formula (I) in which R1, R11 and A have the meanings as given in the description are novel effective iNOS inhibitors.

Abstract: The compounds of formula (I) In which R1, R2, R3, R4, R5 and A have the meanings as given in the description are novel effective iNOS inhibitors.

Abstract: The compounds of formula (I) in which R1, R2, R3, R4, R5 and A have the meanings as given in the description are novel effective iNOS inhibitors.

Abstract: The compounds of Formula (I) in which R1, R2, R3, R4, R5 and A have the meanings as given in the description are novel effective iNOS inhibitors.

Abstract: The compounds of Formula (I) in which R1, R2, R3, R4, R5 and A have the meanings as given in the description are novel effective iNOS inhibitors.

Abstract: Compounds of a certain formula 1 in which R1 and R2 have the meanings indicated in the description are novel kinase inhibitors. Formula (1), in which R1 is phenyl, phenyl substituted by R3 and/or R4, naphthalenyl, naphthalenyl substituted by and/or R6, aryl1, aryl1 substituted by R7 and/or R8, R9, R10 or R11, R2 is phenyl, phenyl substituted by R12 and/or R13, naphthalenyl, naphthalenyl substituted by R14 and/or R15, aryl2, aryl2 substituted by R16 and/or R17 or a radical selected from Formula (2).

Abstract: The compounds of formula I in which R1, R2, R3 and A have the meanings as given in the description are novel effective INOS inhibitors.

Abstract: The compounds of Formula (I) in which R1, R2, Het1 and A have the meanings as given in the description are novel effective iNOS inhibitors.

Abstract: The compounds of formula (I) in which R1, R2, R3, R4, R5 and A have the meanings as given in the description are novel effective iNOS inhibitors.

Abstract: The compounds of Formula (I) in which R1, R2, R3, R4, R5 and A have the meanings as given in the description are novel effective iNOS inhibitors.

Abstract: The invention describes the use of Tetrahydrobiopterin (BH4) or derivatives thereof for the treatment of COPD. In a preferred embodiment, BH4 or derivates thereof are combined with arginine or derivatives thereof.

Abstract: The compounds of Formula (I) in which R1, R2, R3, R4, R5 and A have the meanings as given in the description are novel effective iNOS inhibitors.

Abstract: Novel surfactant protein C esters suitable for preparing pharmaceutical compositions for the treatment of infant respiratory distress syndrome and adult respiratory distress syndrome are described.

Abstract: The compounds of Formula (I) in which R1, R2, R3, R4, R5 and A have the meanings as given in the description are novel effective iNOS inhibitors.

Abstract: The compounds of formula I in which R1 is 1–4C-alkoxy, A is 1–4C-alkylene, B represents 3H-imidazo[4,5-b]pyridin-2-yl, 3H-imidazo[4,5-b]pyridin-2-yl substituted by R2 and/or R3, 9H-purin-8-yl or 9H-purin-8-yl substituted by R4 and/or R5, are effective iNOS inhibitors.

Abstract: The compounds of formula I in which R1, R2, R3 and A have the meanings as given in the description are novel effective INOS inhibitors.

Abstract: Novel surfactant protein C esters suitable for preparing pharmaceutical compositions for the treatment of infant respiratory distress syndrome and adult respiratory distress syndrome are described.